Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Lymphoma × Early Intervention, Educational × Clear all

Phase

Status

Completed 6 Active not recruiting 3 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 8 Colorectal Neoplasms 6 Breast Neoplasms 6 Lung Neoplasms 4 Anatomic Stage I Breast Cancer AJCC v8 3 Melanoma 2 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Spondylitis, Ankylosing 1 Sarcoma 1 Pyloric Stenosis, Hypertrophic 1 Psoriasis 1 Overweight 1 Obesity 1 Neoplasm Metastasis 1 Malignant Solid Neoplasm 1 Lymphoma 1 Lupus Erythematosus, Systemic 1 Inflammatory Bowel Diseases 1 Hematopoietic and Lymphoid System Neoplasm 1 Hematologic Neoplasms 1 Health Education 1 Glioblastoma 1 Financial Stress 1 Esophageal Neoplasms 1 Crohn Disease 1 Colitis, Ulcerative 1 Chemotherapy-Induced Peripheral Neuropathy 1 Caregiver Burden 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Cyclophosphamide 27 fludarabine 18 Rituximab 16 obinutuzumab 11 venetoclax 9 Lenalidomide 9 Bendamustine Hydrochloride 9 Prednisone 7 zanubrutinib 5 pembrolizumab 5 ibrutinib 5 Exercise 5 Etoposide 5 Doxorubicin 5 Blood Specimen Collection 5 Biopsy 5 fludarabine phosphate 4 Vincristine 4 Mesna 4 Cytarabine 4 tafasitamab 3 loncastuximab tesirine 3 glofitamab 3 axicabtagene ciloleucel 3 acalabrutinib 3 Trimethoprim, Sulfamethoxazole Drug Combination 3 Temozolomide 3 Surveys and Questionnaires 3 Radiotherapy 3 Palliative Care 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05006482 2026-01-13

GEM-S

University of Rochester

Phase 3 Recruiting

Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡